公开(公告)号：US20170273940A1

公开(公告)日：2017-09-28

申请号：US15619936

申请日：2017-06-12

Applicant: Houlei Teng ,  Wei Wu ,  CHANGZHOU DEZE MEDICAL SCIENCE CO., LTD

Inventor： Houlei TENG ,  Wei Wu ,  Jingzhuo Zhang ,  Zhe Lin

IPC: A61K31/352 ,  A61K9/20 ,  C07D407/04 ,  A61K9/00 ,  A61K31/4375 ,  C07D455/04

CPC classification number: A61K31/352 ,  A61K9/0095 ,  A61K9/06 ,  A61K9/1635 ,  A61K9/1652 ,  A61K9/19 ,  A61K9/20 ,  A61K9/2027 ,  A61K9/2054 ,  A61K9/2059 ,  A61K9/4866 ,  A61K31/4375 ,  A61P3/00 ,  C07D407/04 ,  C07D455/03 ,  C07D455/04

Abstract: The present invention provides a mangiferin-6-O-berberine salt and a preparation method thereof, and further provides a use of the mangiferin-6-O-berberine salt for the treatment of diabetics and other diseases as an AMPK activator.